Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy
Titel:
Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy
Auteur:
Jolles, S. Bernatowska, E. de Gracia, J. Borte, M. Cristea, V. Peter, H.H. Belohradsky, B.H. Wahn, V. Neufang-Hüber, J. Zenker, O. Grimbacher, B.